| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |